230 results on '"Staender, Sonja"'
Search Results
2. Dupilumab improves pruritus and skin lesions in patients with prurigo nodularis: Pooled results from 2 phase 3 trials (LIBERTY-PN PRIME and PRIME2)
3. Skin Innervation
4. Similarities and differences in peripheral itch and pain pathways in atopic dermatitis
5. Incident Comorbidity, Resource Use, and All-Cause Mortality Associated with Prurigo Nodularis: A United Kingdom Retrospective Database Analysis
6. Clinical aspects and management of chronic itch
7. Pruritus and Prurigo
8. Transcriptomic, Epigenomic, and Neuroanatomic Signatures Differ in Chronic Prurigo, Atopic Dermatitis, and Brachioradial Pruritus
9. Mechanisms and therapeutic targets for neuropathic itch
10. Cutaneous neuroimmune crosstalk in pruritus
11. Transcriptomic characterization of prurigo nodularis and the therapeutic response to nemolizumab
12. Measurement Properties of Patient-Reported Outcome Measures for Pruritus: An Updated Systematic Review
13. A group of cationic amphiphilic drugs activates MRGPRX2 and induces scratching behavior in mice
14. Navigating the evolving landscape of atopic dermatitis:Challenges and future opportunities: The 4th Davos declaration
15. Racial differences in dermatologic conditions associated with HIV: A cross-sectional study of 4679 patients in an urban tertiary care center
16. Diagnostic and treatment algorithm for chronic nodular prurigo
17. Peripheral Sensitization and Loss of Descending Inhibition Is a Hallmark of Chronic Pruritus
18. Pruritus und Prurigo
19. Current treatment strategies in refractory chronic pruritus
20. Current pharmaceutical developments in atopic dermatitis
21. Serlopitant reduced pruritus in patients with prurigo nodularis in a phase 2, randomized, placebo-controlled trial
22. Association between itch and cancer in 16,925 patients with pruritus: Experience at a tertiary care center
23. General Principles and Guidelines
24. NK-1 Antagonists
25. Other Forms of Neuropathic Pruritus
26. Brachioradial Pruritus
27. Clinical Presentation of Itch
28. Humanistic burden of chronic pruritus in patients with inflammatory dermatoses: Results of the European Academy of Dermatology and Venereology Network on Assessment of Severity and Burden of Pruritus (PruNet) cross-sectional trial
29. Serlopitant for the treatment of chronic pruritus: Results of a randomized, multicenter, placebo-controlled phase 2 clinical trial
30. Future Perspectives: New and Modern Therapies
31. Measurement of Itch: Patient-Reported Outcomes
32. Classification
33. Patient-Reported Outcome Measures in Pruritus: A Systematic Review of Measurement Properties
34. Assessment of severity and burden of pruritus
35. NK-1 Antagonists and Itch
36. Other Systemic Treatments
37. Brachioradial Pruritus
38. Neuroreceptors and Neuromediators
39. Hersteller der Münsteraner Moulagen
40. Entstehung der Münsteraner Moulagensammlung
41. Geschichte der Universitäts-Hautklinik Münster
42. Non-Neuronal Kappa Opioid Pathway Profiling in the Skin of Different Chronic Pruritus–Associated Dermatoses
43. Menthol
44. Does single-source create an added value? Evaluating the impact of introducing x4T into the clinical routine on workflow modifications, data quality and cost–benefit
45. A Synthetic Sandalwood Odorant Induces Wound-Healing Processes in Human Keratinocytes via the Olfactory Receptor OR2AT4
46. Pruritus
47. 6 - Pruritus and Dysesthesia
48. Juckreiz: Neues zur Pathophysiologie und Therapie
49. 51876 Impact of Long-Term Abrocitinib Treatment on Patient-Reported Outcomes and Quality of Life for Approximately 2 Years in Patients With Moderate-to-Severe Atopic Dermatitis: An Interim Analysis of JADE EXTEND, a Long-Term Extension Study
50. 52100 Improvement of itch and sleep disturbance symptoms in patients with moderate-to-severe atopic dermatitis treated with lebrikizumab is maintained over 52 weeks as measured weekly with POEM
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.